SCHEMBL7145960

SCHEMBL7145960

CC(C)(C)OC(=O)Nc1cc(OC(C)(C)C)c(-c2ccccc2F)cc1NC(=O)CC(=O)c1cccc(C#N)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 1/20 0.36
GSK3B P49841 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
HDAC3 O15379 1/20 0.35
DHODH Q02127 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
KCNQ4 P56696 1/20 0.33
KCNQ5 Q9NR82 1/20 0.33
RORC P51449 1/20 0.33
CHRM3 P20309 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139979 0.93 ALDH1A1 (0.40) EGLN2GSK3BSIRT2SIRT1HDAC3
SCHEMBL7140101 0.92 KCNQ4 (0.36) EGLN2GSK3BSIRT2SIRT1HDAC3
SCHEMBL7704530 0.92 DHODH (0.37) GSK3BHDAC3DHODHMEN1KMT2A
SCHEMBL7142038 0.90 HTT (0.36) EGLN2GSK3BSIRT2SIRT1HDAC3
SCHEMBL7145884 0.88 KCNQ4 (0.39) EGLN2GSK3BSIRT2SIRT1DHODH
SCHEMBL5868909 0.86 KCNQ4 (0.38) EGLN2GSK3BSIRT2SIRT1HDAC3
SCHEMBL7141050 0.86 CYP17A1 (0.35) EGLN2DHODHMEN1KMT2AKCNQ4
SCHEMBL7141522 0.85 ALDH1A1 (0.42) EGLN2GSK3BSIRT2SIRT1MEN1
SCHEMBL7143926 0.83 DHODH (0.34) EGLN2DHODHKCNQ4KCNQ5CHRM3
SCHEMBL5869026 0.82 KCNQ4 (0.37) EGLN2GSK3BSIRT2SIRT1HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed